Birchview Capital, LP ACAD Holdings History
Birchview Capital, LP's ACADIA Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Birchview Capital, LP held 263,400.00 shares of ACADIA Pharmaceuticals Inc(ACAD), totaling $4.38 Mil. This investment constitutes 3.8% of their stock portfolio, and Birchview Capital, LP now holds 0.16% of the outstanding ACADIA Pharmaceuticals Inc(ACAD) stock.
The initial trade took place in 2019Q2. And since then Birchview Capital, LP has made 10 purchases of ACAD, at an average price of $28.19, for a total of 409,400.00 shares. In addition, there have been 3 sales at an average price of $17.87 for 146,000.00 shares. Based on historical transaction data and ACAD's current price of $22.12, Birchview Capital, LP's estimated gain on his ACAD holdings is $-3.11 Mil, reflecting a -26.92% gain to date.
Birchview Capital, LP ACAD ($22.12) Holding Chart
Birchview Capital, LP ACAD ($22.12) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
